Systemic and local cytokine kinetics after total hip replacement surgery

European Surgical Research

Volumn 41, Issue 4, 2008, Pages 334-340

  Bastian, D ^a   Tamburstuen, M V ^a   Lyngstadaas, S P ^a   Reikeras O ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytokine kinetics, local, systemic; Interleukin 1 receptor antagonist; Interleukins 6, 8; Total hip replacement

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HUMAN; INFLAMMATION; MALE; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; SURGICAL INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TOTAL HIP PROSTHESIS; VENOUS BLOOD;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52249096395     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000157176     Document Type: Article

References (44)

1. Gharaee-Kermani M, Phan SH: Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des 2001;7:1083-1103.
2. Bastian D, Shegarfi H, Rolstad B, Naper C, Lyngstadaas SP, Reikeras O: Investigation of lipopolysaccharide receptor expression on human monocytes after major orthopaedic surgery. Eur Surg Res 2007;40:239-245.
3. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996;24:1125-1128.
4. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994;15:74-80.
5. Haziot A, Rong GW, Lin XY, Silver J, Goyert SM: Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J Immunol 1995;154:6529-6532.
6. Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990;348:550-552.
7. Deans KJ, Haley M, Natanson C, Eichacker PQ, Minneci PC: Novel therapies for sepsis: a review. J Trauma 2005;58:867-874.
8. Fisher CJ, Agosti JM, Opal SM, et al: Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. N Engl J Med 1996;334:1697-1702.
9. Skaga NO, Eken T, Sovik S, Jones JM, Steen PA: Pre-injury ASA physical status classification is an independent predictor of mortality after trauma. J Trauma 2007;63:972-978.
10. Dalen T, Engstrom KG: Microrheology of filtered autotransfusion drain blood with and without leukocyte reduction. Clin Hemorheol Microcirc 1999;21:113-123.
11. Kvarnstrom A, Schmidt A, Tylman M, Jacobsson M, Bengtsson A: Complement split products and proinflammatory cytokines in intraoperatively salvaged unwashed blood during hip replacement: comparison between heparin-coated and non-heparin-coated autotransfusion systems. Vox Sang 2008, E-pub ahead of print.
12. Dinarello CA: Proinflammatory cytokines. Chest 2000;118:503-508.
13. Dimofte G, Alexander A, Carlson G, Little R, Irving M: TNF alpha and IL-6 involvement in surgical trauma. II. In vitro cytokine production. Rev Med Chir Soc Med Nat Iasi 2001;105:493-498.
14. Menger MD, Vollmar B: Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg 2004;389:475-484.
15. Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR: Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med 1985;162:930-942.
16. Pape HC, Schmidt RE, Rice J, et al: Biochemical changes after trauma and skeletal surgery of the lower extremity: quantification of the operative burden. Crit Care Med 2000;28:3441-3448.
17. Sakamoto K, Arakawa H, Mita S, et al: Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine 1994;6:181-186.
18. Perregaux D, Gabel CA: Interleukin-1 beta maturation and release in response to ATP and nigericin: evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 1994;269:15195-203.
19. Perregaux DG, Gabel CA: Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1 alpha and IL-1 beta occurs via a similar mechanism. J Immunol 1998;160:2469-2477.
20. Horn F, Henze C, Heidrich K: Interleukin-6 signal transduction and lymphocyte function. Immunobiology 2000;202:151-167.
21. Ramadori G, Christ B: Cytokines and the hepatic acute-phase response. Semin Liver Dis 1999;19:141-155.
22. Reikeraas O, Sun J, Krohn CD, Wang JE, Aasen AO: Reduced capacity of whole blood leucocytes to express tumour necrosis factor-alpha and interleukin-10 following major orthopaedic surgery. Eur Surg Res 2005;37:210-215.
23. Biffl WL, Moore EE, Moore FA, Peterson VM: Interleukin-6 in the injured patient: marker of injury or mediator of inflammation? Ann Surg 1996;224:647-664.
24. Shenkin A, Fraser WD, Series J, et al: The serum interleukin 6 response to elective surgery. Lymphokine Res 1989;8:123-127.
25. Cruickshank AM, Fraser WD, Burns HJ, Van DJ, Shenkin A: Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond) 1990;79:161-165.
26. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ: Systemic cytokine response after major surgery. Br J Surg 1992;79:757-760.
27. Fey GH, Fuller GM: Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 1987;4:323-338.
28. Kaibara A, Espat NJ, Auffenberg T, et al: Interleukin 6, but not ciliary neutrotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis. Cytokine 1998;10:452-456.
29. Tilg H, Dinarello CA, Mier JW: IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today 1997;18:428-432.
30. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW: Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994;83:113-118.
31. Steensberg A, Fischer CP, Keller C, Moller K, Pedersen BK: IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 2003;285:E433-E437.
32. Yager DR, Kulina RA, Gilman LA: Wound fluids: a window into the wound environment? Int J Low Extrem Wounds 2007;6:262-272.
33. Sheeran P, Hall GM: Cytokines in anaesthesia. Br J Anaesth 1997;78:201-219.
34. Mokart D, Capo C, Blache JL, et al: Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer. Br J Surg 2002;89:1450-1456.
35. Smith KA: Interleukin-2: inception, impact, and implications. Science 1988;240:1169-1176.
36. Sanarico N, Ciaramella A, Sacchi A, et al: Human monocyte-derived dendritic cells differentiated in the presence of IL-2 produce proinflammatory cytokines and prime Th1 immune response. J Leukoc Biol 2006;80:555-562.
37. Moore KW, de Waal MR, Coffman RL, O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
38. Muehlstedt SG, Richardson CJ, Lyte M, Rodriguez JL: Systemic and pulmonary effector cell function after injury. Crit Care Med 2002;30:1322-1326.
39. Randolph GJ, Furie MB: A soluble gradient of endogenous monocyte chemoattractant protein-1 promotes the transendothelial migration of monocytes in vitro. J Immunol 1995;155:3610-3618.
40. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K: Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993;365:654-657.
41. Tsukada K, Omert LA, Menezes J, et al: Neutrophil accumulation and damage to the gastric mucosa in resuscitated hemorrhagic shock is independent of inducible nitric oxide synthase. Shock 1999;11:319-324.
42. Gordon JR, Li F, Zhang X, Wang W, Zhao X, Nayyar A: The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals. J Leukoc Biol 2005;78:1265-1272.
43. Andersson I, Tylman M, Bengtson JP, Bengtsson A: Complement split products and pro-inflammatory cytokines in salvaged blood after hip and knee arthroplasty. Can J Anesth 2001;48:251-255.
44. Bjornsson GL, Thorsteinsson L, Gudmundsson KO, Jonsson H Jr, Gudmundsson S, Gudbjornsson B: Inflammatory cytokines in relation to adrenal response following total hip replacement. Scand J Immunol 2007;65:99-105.